Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting.

Trial Profile

Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2012

At a glance

  • Drugs Influenza virus vaccine; Influenza virus vaccine live
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Acronyms ACES
  • Sponsors MedImmune
  • Most Recent Events

    • 07 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Apr 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
    • 01 Mar 2010 Results of this drug utilisation study were published in the American Journal of Preventive Medicine 38 (3): 237-246.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top